Utilization, Cost, and Outcome of Branded vs Compounded 17-Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Birth

This study compares the utilization, cost, and outcome data from an insurance claims database to determine the difference in treatment efficacy between the branded and compounded versions of 17-alpha hydroxyprogesterone caproate.

Sparad:
Bibliografiska uppgifter
I publikationen:JAMA Intern Med
Huvudupphovsmän: Fried, Inbar, Beam, Andrew L., Kohane, Isaac S., Palmer, Nathan P.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Medical Association 2017
Ämnen:
Research Letter
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820707/
https://ncbi.nlm.nih.gov/pubmed/28973537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.5017
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk